HomeSLNO • NASDAQ
add
Soleno Therapeutics Inc
Previous close
$37.90
Day range
$37.08 - $38.16
Year range
$3.16 - $53.82
Market cap
1.21B USD
Avg Volume
382.25K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.83M | 106.52% |
Net income | -11.30M | -105.91% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -12.34M | -115.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 169.68M | 1,062.04% |
Total assets | 180.69M | 581.93% |
Total liabilities | 23.18M | 43.56% |
Total equity | 157.51M | — |
Shares outstanding | 32.46M | — |
Price to book | 7.63 | — |
Return on assets | -26.26% | — |
Return on capital | -35.32% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -11.30M | -105.91% |
Cash from operations | -6.31M | -22.77% |
Cash from investing | — | — |
Cash from financing | 123.56M | — |
Net change in cash | 117.24M | 2,377.02% |
Free cash flow | -23.58M | -702.73% |
About
Founded
1999
Headquarters
Website
Employees
33
